rs33980500

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147686.4(TRAF3IP2):​c.28G>A​(p.Asp10Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0791 in 1,613,952 control chromosomes in the GnomAD database, including 5,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 820 hom., cov: 32)
Exomes 𝑓: 0.077 ( 4778 hom. )

Consequence

TRAF3IP2
NM_147686.4 missense

Scores

4
3
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:2

Conservation

PhyloP100: 5.11

Publications

149 publications found
Variant links:
Genes affected
TRAF3IP2 (HGNC:1343): (TRAF3 interacting protein 2) This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009]
TRAF3IP2-AS1 (HGNC:40005): (TRAF3IP2 antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147686.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017044842).
BP6
Variant 6-111592059-C-T is Benign according to our data. Variant chr6-111592059-C-T is described in ClinVar as Benign. ClinVar VariationId is 30630.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147686.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF3IP2
NM_147686.4
MANE Select
c.28G>Ap.Asp10Asn
missense
Exon 2 of 9NP_679211.2O43734-2
TRAF3IP2
NM_147200.3
c.55G>Ap.Asp19Asn
missense
Exon 3 of 10NP_671733.2O43734-1
TRAF3IP2
NM_001164281.3
c.28G>Ap.Asp10Asn
missense
Exon 2 of 9NP_001157753.1O43734-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF3IP2
ENST00000368761.11
TSL:1 MANE Select
c.28G>Ap.Asp10Asn
missense
Exon 2 of 9ENSP00000357750.5O43734-2
TRAF3IP2
ENST00000340026.10
TSL:1
c.55G>Ap.Asp19Asn
missense
Exon 3 of 10ENSP00000345984.6O43734-1
TRAF3IP2
ENST00000528599.1
TSL:1
n.223G>A
non_coding_transcript_exon
Exon 2 of 5

Frequencies

GnomAD3 genomes
AF:
0.0953
AC:
14493
AN:
152154
Hom.:
821
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.145
Gnomad AMI
AF:
0.0789
Gnomad AMR
AF:
0.112
Gnomad ASJ
AF:
0.129
Gnomad EAS
AF:
0.00653
Gnomad SAS
AF:
0.0579
Gnomad FIN
AF:
0.0654
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0736
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.0856
AC:
21353
AN:
249574
AF XY:
0.0818
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.143
Gnomad ASJ exome
AF:
0.140
Gnomad EAS exome
AF:
0.00228
Gnomad FIN exome
AF:
0.0724
Gnomad NFE exome
AF:
0.0745
Gnomad OTH exome
AF:
0.0887
GnomAD4 exome
AF:
0.0774
AC:
113140
AN:
1461680
Hom.:
4778
Cov.:
31
AF XY:
0.0771
AC XY:
56048
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.142
AC:
4764
AN:
33472
American (AMR)
AF:
0.138
AC:
6180
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
3670
AN:
26128
East Asian (EAS)
AF:
0.0115
AC:
455
AN:
39700
South Asian (SAS)
AF:
0.0701
AC:
6044
AN:
86238
European-Finnish (FIN)
AF:
0.0721
AC:
3854
AN:
53420
Middle Eastern (MID)
AF:
0.0995
AC:
574
AN:
5768
European-Non Finnish (NFE)
AF:
0.0743
AC:
82651
AN:
1111846
Other (OTH)
AF:
0.0819
AC:
4948
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
5427
10854
16281
21708
27135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3112
6224
9336
12448
15560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0953
AC:
14508
AN:
152272
Hom.:
820
Cov.:
32
AF XY:
0.0928
AC XY:
6911
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.145
AC:
6014
AN:
41528
American (AMR)
AF:
0.112
AC:
1707
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
449
AN:
3472
East Asian (EAS)
AF:
0.00655
AC:
34
AN:
5194
South Asian (SAS)
AF:
0.0588
AC:
284
AN:
4830
European-Finnish (FIN)
AF:
0.0654
AC:
694
AN:
10616
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0736
AC:
5008
AN:
68014
Other (OTH)
AF:
0.102
AC:
216
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
663
1326
1989
2652
3315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0785
Hom.:
1770
Bravo
AF:
0.102
Asia WGS
AF:
0.0420
AC:
148
AN:
3478
EpiCase
AF:
0.0769
EpiControl
AF:
0.0736

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Candidiasis, familial, 8 (1)
-
-
-
not provided (1)
-
-
-
Psoriasis 13, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.40
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.26
T
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
5.1
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.11
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.14
T
Varity_R
0.38
gMVP
0.36
Mutation Taster
=295/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs33980500;
hg19: chr6-111913262;
COSMIC: COSV60675431;
COSMIC: COSV60675431;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.